For the millions living with multiple sclerosis, the gap between earliest biological change and first clinical symptom represents a critical — and largely wasted — therapeutic window. Research now suggests that neutrophils, long underappreciated in MS pathology relative to T and B cells, may serve as both early sentinels of disease and actionable drug targets, provided their behavior is examined through a circadian lens.
Using the experimental autoimmune encephalomyelitis (EAE) mouse model — the most established preclinical proxy for MS — investigators employed time-of-day-structured screening to characterize neutrophil dynamics. The approach revealed that circulating neutrophils carry detectable disease signatures in blood before overt neurological symptoms appear, positioning them as potential presymptomatic biomarkers. Transcriptomic profiling of neutrophils that had infiltrated the central nervous system further uncovered distinct gene expression patterns, pointing toward molecular pathways that could be selectively targeted therapeutically. The circadian dimension proved functionally meaningful: rhythmic variation in neutrophil behavior influenced which targets were most accessible at specific times.
This work intersects two rapidly evolving fields — neuroimmunology and chronobiology — in a way that carries real translational weight, though important caveats apply. EAE captures certain aspects of MS pathology but is an imperfect human surrogate; the model tends to reflect relapsing-remitting and some progressive features while missing others. Neutrophil biology in human MS has historically received less attention than lymphocyte-driven mechanisms, so replication in human cohorts with time-stamped sampling protocols will be essential before clinical translation. That said, the framing is conceptually significant: if neutrophil transcriptomic states fluctuate on circadian schedules, then biomarker validity and drug target accessibility may both be time-dependent — a practical implication for how future MS trials design blood collection windows. This is an incremental but directionally important finding that reframes neutrophils as circadian-responsive actors in CNS autoimmunity.